The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 09, 2025
Filed:
Jan. 18, 2024
Applicant:
Ads Therapeutics Llc, Irvine, CA (US);
Inventors:
Jinsong Ni, Irvine, CA (US);
Rong Yang, Irvine, CA (US);
Assignee:
ADS Therapeutics LLC, Irvine, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/496 (2006.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 9/107 (2006.01); A61K 31/365 (2006.01); A61K 31/404 (2006.01); A61K 31/407 (2006.01); A61K 31/416 (2006.01); A61K 31/4412 (2006.01); A61K 31/4439 (2006.01); A61K 31/444 (2006.01); A61K 31/4709 (2006.01); A61K 31/506 (2006.01); A61K 31/513 (2006.01); A61K 31/517 (2006.01); A61K 31/519 (2006.01); A61K 31/52 (2006.01); A61K 31/675 (2006.01); A61K 45/06 (2006.01); A61K 47/02 (2006.01); A61K 47/10 (2017.01); A61K 47/18 (2017.01); A61K 47/26 (2006.01); A61K 47/36 (2006.01); A61K 47/40 (2006.01); A61P 27/02 (2006.01); A61P 27/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/496 (2013.01); A61K 9/0048 (2013.01); A61K 9/0051 (2013.01); A61K 9/08 (2013.01); A61K 9/107 (2013.01); A61K 31/365 (2013.01); A61K 31/404 (2013.01); A61K 31/407 (2013.01); A61K 31/416 (2013.01); A61K 31/4412 (2013.01); A61K 31/4439 (2013.01); A61K 31/444 (2013.01); A61K 31/4709 (2013.01); A61K 31/506 (2013.01); A61K 31/513 (2013.01); A61K 31/517 (2013.01); A61K 31/519 (2013.01); A61K 31/52 (2013.01); A61K 31/675 (2013.01); A61K 45/06 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/183 (2013.01); A61K 47/186 (2013.01); A61K 47/26 (2013.01); A61K 47/36 (2013.01); A61K 47/40 (2013.01); A61P 27/02 (2018.01); A61P 27/06 (2018.01);
Abstract
Compositions and methods of using nintedanib for treating indications with abnormal neovascularization in the front part of the eye are disclosed.
Ni, Jinsong. (2025). Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularization (U.S. Patent No. 12491183). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12491183
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile